Joseph, Rosalia N.
Mwema, Tabeth
Eiseb, Seth J.
Maliti, Deodatus V.
Tambo, Munyaradzi
Iitula, Iitula
Eloff, Lydia
Lukubwe, Ophilia
Smith-Gueye, Cara
Vajda, Élodie A.
Tatarsky, Allison
Katokele, Stark T.
Uusiku, Petrina N.
Walusimbi, Dennis
Ogoma, Sheila B.
Mumbengegwi, Davis R.
Lobo, Neil F.
Funding for this research was provided by:
Bill and Melinda Gates Foundation (Inv-009652, #CHGMALMELIM5/BMGFMELIM4)
Global Fund to Fight AIDS, Tuberculosis and Malaria (#NAM-Z-NVDCP 2021-2023)
Article History
Received: 2 October 2023
Accepted: 2 March 2024
First Online: 14 March 2024
Declarations
:
: This study was part of a larger study being conducted by the Ministry of Health and Social Services (MoHSS), National Vector-borne Disease Control Programme (NVDCP). This study was authorized by the MoHSS Biomedical Research Ethics Committee and the University of Namibia Health Research Ethics Committee. Informed consent forms were provided to all the blood volunteers, and they were required to read and understand the content of the consent and ask questions and clarification. The volunteers were tested for malaria each Monday of the week; all the rapid diagnostic tests (RDT) for malaria were conducted by a qualified nurse from the MoHSS. The participants were also compensated for their time and effort.
: Not applicable.
: The authors declare that they have no competing interests.